HSHHSH Health Technology Supplier Hub

All suppliers

Showing 226–250 of 278

SOPHiA GENETICSHQ Switzerland · Europe
Clinical AI & decision supportGenomics & precision medicine

FY2025 revenue $77.3m (+19.0%); operating margin -91.7%; net loss $79.0m.

Balance sheet figures not captured from release.

Financial health: WeakRisk summary →
No reviews yet
View profile
SophosHQ United Kingdom · Europe
Cyber security

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
SpokHQ United States · North America
Clinical communications & nurse call

FY2025 revenue $139.7m (+1.5%); operating margin 14.1%; net income $15.9m.

No debt; $25.3m cash.

Financial health: StrongRisk summary →
No reviews yet
View profile
Strata Decision TechnologyHQ United States · North America
ERP, finance & supply chain

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
StrykerHQ United States · North America
Clinical communications & nurse callMedical devices & monitoringSurgical & theatre systems

FY2025 revenue $25.12bn (+11.2%); operating margin 19.5%; net income $3.25bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
SukiHQ United States · North America
Clinical AI & decision support

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Surgical Information SystemsHQ United States · North America
Surgical & theatre systems

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Swisslog HealthcareHQ Switzerland · Europe
Pharmacy & medicines management

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Sword HealthHQ United States · North America
Digital therapeutics & appsRemote monitoring & virtual wards

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
symplrHQ United States · North America
ERP, finance & supply chainWorkforce & rostering

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
SysmexHQ Japan · Asia-Pacific
Diagnostics & IVDLaboratory & pathology (LIMS)

FY2025 revenue ¥500.0bn (-1.7%); operating margin 10.4%; net income ¥35.5bn.

Balance sheet figures not captured from release.

Financial health: StrongRisk summary →
No reviews yet
View profile
System CHQ United Kingdom · Europe
Electronic health records (EHR/EPR)Mental health, community & social care

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
SystematicHQ Denmark · Europe
Electronic health records (EHR/EPR)

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
TebraHQ United States · North America
Electronic health records (EHR/EPR)Revenue cycle, billing & claims

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Teladoc HealthHQ United States · North America
Remote monitoring & virtual wardsTelehealth & virtual care

FY2025 revenue $2.53bn (-1.5%); operating margin -10.4%; net loss $200.3m.

Cash $781.1m; debt $994.9m.

Financial health: WeakRisk summary →
No reviews yet
View profile
TeleTracking TechnologiesHQ United States · North America
Patient flow & operations

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Telstra HealthHQ Australia · Asia-Pacific
Electronic health records (EHR/EPR)Pharmacy & medicines managementTelehealth & virtual care

Parent Telstra Group (TLS.AX) FY2026 group net income about A$2.40bn (+2.7%).

Revenue and operating profit not yet captured, so financial health not assessed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
TELUS HealthHQ Canada · North America
Electronic health records (EHR/EPR)Pharmacy & medicines managementPrimary care systems

Part of TELUS (T.TO).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
TempusHQ United States · North America
Clinical AI & decision supportGenomics & precision medicine

FY2025 revenue $1.27bn (+83.4%); operating margin -19.9%; net loss $245.0m.

Cash $759.7m; debt $1.24bn.

Financial health: WeakRisk summary →
No reviews yet
View profile
TerumoHQ Japan · Asia-Pacific
Medical devices & monitoring

Listed (4543.T).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
The Access GroupHQ United Kingdom · Europe
Electronic health records (EHR/EPR)ERP, finance & supply chainWorkforce & rostering

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
Thermo Fisher ScientificHQ United States · North America
Clinical trials & life sciencesDiagnostics & IVDLaboratory & pathology (LIMS)

FY2025 revenue $44.56bn (+3.9%); operating margin 17.4%; net income $6.70bn.

Cash $9.85bn; debt $39.38bn.

Financial health: StrongRisk summary →
No reviews yet
View profile
TietoevryHQ Finland · Europe
Electronic health records (EHR/EPR)

Listed (TIETO.HE).

Latest full-year results not yet captured by HSH.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
TigerConnectHQ United States · North America
Clinical communications & nurse call

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile
TotalmobileHQ United Kingdom · Europe
Workforce & rostering

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Financial health: Not assessedRisk summary →
No reviews yet
View profile